尽管这项研究无法证明是筛查的减少导致了诊断数的下降,但作者们认为这是最合理的解释。
The findings were based on data from cancer registries and national surveys that asked men about prostate screening.
上述研究结果依据的是来自癌症登记局和有关前列腺筛查的全国性调查的数据。
A second study, by researchers from several medical centers, also found a significant decline in PSA testing after the 2017 task force recommendations.
在另一项研究中,多家医疗中心的研究人员也发现,自2017年工作组提出建议后,PSA检测显著减少了。
“With PSA testing, we often detect cancers that don’t need to be treated — clinically indolent, meaningless cancers,” Dr. Penson said in an interview. “It is true that more men die with prostate cancer than of it.”
“在PSA检测中,我们经常会发现临床上不活跃,也就是没有治疗意义的癌症,”彭森博士在接受采访时说。“但死于前列腺癌的男性要多于此,这也是事实。”
He said the recognition that many prostate cancers were indolent, or slow-growing, and not deadly had led to major changes in medical practice, making doctors less inclined to automatically operate if cancer is found.
他说,认识到许多前列腺癌并不活跃/生长缓慢/并不致命导致了医疗实践中的重大改变,医生们不像过去那样一发现癌症就不假思索地准备做手术。
【男性究竟该不该做前列腺癌筛查】相关文章:
最新
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15
2020-09-15